公司资料
iCAD, Inc. 股价、新闻与催化剂
已退市
- 股票代码:
- ICAD
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
目前无法获取 ICAD 的收盘价变动背景。
公司概览
业务概览
iCAD is a medical imaging and cancer-detection company focused on AI-enabled breast health and workflow software. Its business sits at the intersection of imaging, detection, and software.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, iCAD sits in medtech and diagnostics.
商业模式特征
The company depends on product adoption, imaging workflow integration, and the monetization of its cancer-detection platform.
生物医药行业定位
iCAD is outside biotech and belongs to the imaging and diagnostics layer.
未来催化剂
- iCAD’s catalysts are ProFound AI adoption and breast-cancer detection workflow growth. The market will care about whether AI mammography keeps translating into durable clinical usage.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。